More on IPHA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (5/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Innate Pharma (NQ:IPHA)
Delayed: 1.60 +0.02 (1.27%)
Prev. Close $1.58  
Open$1.61 
52 Wk High$ 
52 Wk Low$ 
Day High$1.63 
Day Low$1.58 
P/E N/A  
EPS$ 
Volume5,280 

Friends, Peers and Foes (?): IPH AUTL (more...)

Feb 19, 2026 01:00 AM Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
Feb 18, 2026 01:00 AM Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
Jan 7, 2026 01:00 AM Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025
Dec 22, 2025 01:01 AM Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
Dec 11, 2025 01:00 AM Innate Pharma Releases Its 2026 Financial Calendar
Nov 28, 2025 01:01 AM Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
Nov 17, 2025 01:01 AM Innate Pharma to Present at Jefferies Global Healthcare Conference
Nov 13, 2025 01:00 AM Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
Nov 10, 2025 01:01 AM Innate Pharma gets FDA clearance for phase 3 CTCL trial
Nov 10, 2025 01:01 AM Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
View All Articles

Entities mentioned with IPHA

View All Entities